Thioredoxin reductase: A novel, independent prognostic marker in patients with hepatocellular carcinoma

Here we found that hepatocellular carcinoma (HCC) patients with recurrence outcome and nonsurvivors had significantly increased thioredoxin reductase (TrxR) serum levels on reoperation (P < 0.0001 and P < 0.0001). Multivariate regression analysis adjusted for common risk factors showed that Tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chunyan, Peng, Yan, Mao, Binglang, Qian, Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627346/
https://www.ncbi.nlm.nih.gov/pubmed/25970775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627346/
https://www.ncbi.nlm.nih.gov/pubmed/25970775

Ejemplares similares